Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

Male hormones and their interactions are crucial for male sexual development and characteristics.

A man developed hair loss from testosterone treatment but improved with additional medication.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

5alpha-reductase 2 is crucial for proper male brain development and sexual differentiation.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Postmenopausal hyperandrogenism involves excess male hormones causing symptoms like hair growth and acne, and requires ruling out tumors and other disorders.

Genetic mutations can affect female sexual development, requiring personalized medical care.

A new gene mutation causes complete androgen insensitivity in a 16-year-old with a female appearance.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

A 15-year-old girl with rare reproductive disorders received hormone therapy to develop secondary sexual traits, but infertility persisted.

Understanding genes and hormones is crucial for managing male puberty and sex development disorders.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

A postmenopausal woman's masculine symptoms improved after surgery for a hormone-producing ovarian tumor.

Testosterone increases hair growth and acne in transgender men.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

A postmenopausal woman's virilization was caused by a rare ovarian tumor that was hard to detect but was successfully treated with surgery.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

The conclusion is that certain surgeries can help people with gender dysphoria look more like their true gender and feel better.